-
Je něco špatně v tomto záznamu ?
Abnormal Cerebrospinal Fluid Cytology in Functional Movement Disorders
T. Serranová, M. Slovák, Z. Forejtová, T. Sieger, P. Dušek, B. Srpová, K. Mrázová, E. Růžička, K. Šonka, AJ. Espay, P. Nytrová
Jazyk angličtina Země Spojené státy americké
Typ dokumentu časopisecké články
- MeSH
- biologické markery mozkomíšní mok MeSH
- cytologie MeSH
- dospělí MeSH
- konverzní poruchy mozkomíšní mok patofyziologie MeSH
- lidé středního věku MeSH
- lidé MeSH
- počet leukocytů MeSH
- pohybové poruchy * mozkomíšní mok patofyziologie MeSH
- Check Tag
- dospělí MeSH
- lidé středního věku MeSH
- lidé MeSH
- mužské pohlaví MeSH
- ženské pohlaví MeSH
- Publikační typ
- časopisecké články MeSH
OBJECTIVE: The role of inflammation and neuroimmune mechanisms, which have been documented in various neuropsychiatric disorders including the seizure subtype of functional neurological disorder, remains unclear in functional movement disorders (FMD). To explore these mechanisms, we analyzed selected inflammatory markers in cerebrospinal fluid (CSF) in patients with FMD. METHODS: We compared CSF markers in 26 patients with clinically established FMD (20 females; mean [SD] age = 43.3 [10.9], disease duration = 3.9 [3], range = 0.1-11 years; mean follow-up after lumbar puncture = 4.3 [2] years, range = 0.5-7 years) and 26 sex- and age-matched clinical controls with noninflammatory nonneurodegenerative neurological disorders, mostly sleep disorders. RESULTS: Sixty-five percent of FMD patients versus 15% of controls showed cytological abnormalities (i.e., increased white blood cells [WBC] count, signs of WBC activation, or both; odds ratio [OR] = 9.85, 95% confidence interval = 2.37-52.00, p < .01, corrected), with a significantly higher frequency of an isolated lymphocytic activation, 35% versus 0% (OR = ∞, 95% confidence interval = 2.53-∞, p < .05, corrected). There were no differences in CSF protein and albumin levels, quotient albumin, IgG index, and oligoclonal bands. CSF abnormalities were not associated with more severe motor symptoms or a higher frequency of depression in FMD. CONCLUSIONS: Our results suggest a possible involvement of immune mechanisms in the pathophysiology of (at least a subtype of) FMD that deserves further investigation.
Citace poskytuje Crossref.org
- 000
- 00000naa a2200000 a 4500
- 001
- bmc24019934
- 003
- CZ-PrNML
- 005
- 20241024110857.0
- 007
- ta
- 008
- 241015s2024 xxu f 000 0|eng||
- 009
- AR
- 024 7_
- $a 10.1097/PSY.0000000000001307 $2 doi
- 035 __
- $a (PubMed)38573035
- 040 __
- $a ABA008 $b cze $d ABA008 $e AACR2
- 041 0_
- $a eng
- 044 __
- $a xxu
- 100 1_
- $a Serranová, Tereza $u From the Department of Neurology and Center of Clinical Neuroscience, Charles University (Serranová, Slovák, Forejtová, Sieger, Dušek, Srpová, Růžička, Šonka, Nytrová), 1st Faculty of Medicine and General University Hospital in Prague; Department of Cybernetics, Faculty of Electrical Engineering (Sieger), Czech Technical University in Prague; Institute of Medical Biochemistry and Laboratory Diagnostics (Mrázová), Charles University, 1st Faculty of Medicine and General University Hospital in Prague, Prague, Czech Republic; and James J. and Joan A. Gardner Family Center for Parkinson's Disease and Movement Disorders, Department of Neurology (Espay), University of Cincinnati, Cincinnati, Ohio
- 245 10
- $a Abnormal Cerebrospinal Fluid Cytology in Functional Movement Disorders / $c T. Serranová, M. Slovák, Z. Forejtová, T. Sieger, P. Dušek, B. Srpová, K. Mrázová, E. Růžička, K. Šonka, AJ. Espay, P. Nytrová
- 520 9_
- $a OBJECTIVE: The role of inflammation and neuroimmune mechanisms, which have been documented in various neuropsychiatric disorders including the seizure subtype of functional neurological disorder, remains unclear in functional movement disorders (FMD). To explore these mechanisms, we analyzed selected inflammatory markers in cerebrospinal fluid (CSF) in patients with FMD. METHODS: We compared CSF markers in 26 patients with clinically established FMD (20 females; mean [SD] age = 43.3 [10.9], disease duration = 3.9 [3], range = 0.1-11 years; mean follow-up after lumbar puncture = 4.3 [2] years, range = 0.5-7 years) and 26 sex- and age-matched clinical controls with noninflammatory nonneurodegenerative neurological disorders, mostly sleep disorders. RESULTS: Sixty-five percent of FMD patients versus 15% of controls showed cytological abnormalities (i.e., increased white blood cells [WBC] count, signs of WBC activation, or both; odds ratio [OR] = 9.85, 95% confidence interval = 2.37-52.00, p < .01, corrected), with a significantly higher frequency of an isolated lymphocytic activation, 35% versus 0% (OR = ∞, 95% confidence interval = 2.53-∞, p < .05, corrected). There were no differences in CSF protein and albumin levels, quotient albumin, IgG index, and oligoclonal bands. CSF abnormalities were not associated with more severe motor symptoms or a higher frequency of depression in FMD. CONCLUSIONS: Our results suggest a possible involvement of immune mechanisms in the pathophysiology of (at least a subtype of) FMD that deserves further investigation.
- 650 _2
- $a lidé $7 D006801
- 650 _2
- $a mužské pohlaví $7 D008297
- 650 _2
- $a ženské pohlaví $7 D005260
- 650 _2
- $a dospělí $7 D000328
- 650 _2
- $a lidé středního věku $7 D008875
- 650 12
- $a pohybové poruchy $x mozkomíšní mok $x patofyziologie $7 D009069
- 650 _2
- $a konverzní poruchy $x mozkomíšní mok $x patofyziologie $7 D003291
- 650 _2
- $a počet leukocytů $7 D007958
- 650 _2
- $a biologické markery $x mozkomíšní mok $7 D015415
- 650 _2
- $a cytologie $7 D000093222
- 655 _2
- $a časopisecké články $7 D016428
- 700 1_
- $a Slovák, Matěj
- 700 1_
- $a Forejtová, Zuzana
- 700 1_
- $a Sieger, Tomáš
- 700 1_
- $a Dušek, Petr
- 700 1_
- $a Srpová, Barbora
- 700 1_
- $a Mrázová, Kateřina
- 700 1_
- $a Růžička, Evžen
- 700 1_
- $a Šonka, Karel
- 700 1_
- $a Espay, Alberto J
- 700 1_
- $a Nytrová, Petra
- 773 0_
- $w MED00003994 $t Psychosomatic medicine $x 1534-7796 $g Roč. 86, č. 6 (2024), s. 555-560
- 856 41
- $u https://pubmed.ncbi.nlm.nih.gov/38573035 $y Pubmed
- 910 __
- $a ABA008 $b sig $c sign $y - $z 0
- 990 __
- $a 20241015 $b ABA008
- 991 __
- $a 20241024110851 $b ABA008
- 999 __
- $a ok $b bmc $g 2202263 $s 1231907
- BAS __
- $a 3
- BAS __
- $a PreBMC-MEDLINE
- BMC __
- $a 2024 $b 86 $c 6 $d 555-560 $e 20240325 $i 1534-7796 $m Psychosomatic medicine $n Psychosom Med $x MED00003994
- LZP __
- $a Pubmed-20241015